SCH900776
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCH900776, covering 2012-08-28 to 2012-08-28. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors [Phase 1]